ArticleInternational journal of molecular sciences2022

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.

Naila Rabbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.